company background image
0KSX logo

Quest Diagnostics LSE:0KSX Stock Report

Last Price

US$128.28

Market Cap

US$14.3b

7D

0.6%

1Y

-8.5%

Updated

25 Mar, 2024

Data

Company Financials +

Quest Diagnostics Incorporated

LSE:0KSX Stock Report

Market Cap: US$14.3b

0KSX Stock Overview

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally.

0KSX fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance2/6
Financial Health4/6
Dividends5/6

Quest Diagnostics Incorporated Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Quest Diagnostics
Historical stock prices
Current Share PriceUS$128.28
52 Week HighUS$147.55
52 Week LowUS$119.84
Beta0.90
1 Month Change1.61%
3 Month Change-6.39%
1 Year Change-8.50%
3 Year Change1.38%
5 Year Change43.88%
Change since IPO20.32%

Recent News & Updates

Recent updates

Shareholder Returns

0KSXGB HealthcareGB Market
7D0.6%-0.5%2.4%
1Y-8.5%-20.9%4.2%

Return vs Industry: 0KSX exceeded the UK Healthcare industry which returned -21.2% over the past year.

Return vs Market: 0KSX underperformed the UK Market which returned 4.9% over the past year.

Price Volatility

Is 0KSX's price volatile compared to industry and market?
0KSX volatility
0KSX Average Weekly Movement2.5%
Healthcare Industry Average Movement7.7%
Market Average Movement4.7%
10% most volatile stocks in GB Market11.3%
10% least volatile stocks in GB Market2.5%

Stable Share Price: 0KSX has not had significant price volatility in the past 3 months.

Volatility Over Time: 0KSX's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
196744,000Jim Davishttps://www.questdiagnostics.com

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals.

Quest Diagnostics Incorporated Fundamentals Summary

How do Quest Diagnostics's earnings and revenue compare to its market cap?
0KSX fundamental statistics
Market capUS$14.31b
Earnings (TTM)US$850.00m
Revenue (TTM)US$9.25b

16.8x

P/E Ratio

1.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0KSX income statement (TTM)
RevenueUS$9.25b
Cost of RevenueUS$6.18b
Gross ProfitUS$3.07b
Other ExpensesUS$2.22b
EarningsUS$850.00m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 23, 2024

Earnings per share (EPS)7.68
Gross Margin33.17%
Net Profit Margin9.19%
Debt/Equity Ratio75.3%

How did 0KSX perform over the long term?

See historical performance and comparison

Dividends

2.3%

Current Dividend Yield

37%

Payout Ratio

Does 0KSX pay a reliable dividends?

See 0KSX dividend history and benchmarks
When do you need to buy 0KSX by to receive an upcoming dividend?
Quest Diagnostics dividend dates
Ex Dividend DateApr 05 2024
Dividend Pay DateApr 22 2024
Days until Ex dividend10 days
Days until Dividend pay date27 days

Does 0KSX pay a reliable dividends?

See 0KSX dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.